Please note, this OEL/ADE monograph also applies to Pantoprazole Sodium (CAS RN 138786-67-1) and pantoprazole sodiuum sesquihydrate (CAS RN 164579-32-2). Pantoprazole is indicated for gastroesophageal reflux treatment and prevention, high stomach acid secretion, and Zollinger-Ellison Syndrome. Pantoprazole sodium is a proton pump inhibitor that covalently binds to the (H+, K+)- ATPase enzyme system at the secretory surface of the gastric parietal cell. This action suppresses the final step in gastric acid production and leads to inhibition of both basal and stimulated acid secretion.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Pantoprazole, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.